Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in DCIS of the breast
NCT03535506Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Oct 2018
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in ductal carcinoma in situ (DCIS), sponsored by Georgetown University. Started Oct 2018; status: terminated.
02
Drugs
palbociclib
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT03535506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535506.